Platelet transfusions in haematology patients: are we using them appropriately?
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaUse of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopeniaComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationUse of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopeniaLarge-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programmingWhy has demand for platelet components increased? A reviewAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocolProspective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.Functional recovery of stored platelets after transfusion.Computerised decision support systems to promote appropriate use of blood products.Bleeding risk of surgery and its prevention in patients with inherited platelet disordersThe use of an objective structured clinical examination to assess internal medicine residents' transfusion knowledge.Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010.Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitals.Prophylactic platelet transfusions prior to surgery for people with a low platelet count.Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
P2860
Q24186359-A90364E9-5A13-49BC-87D3-17DE154F4FD5Q24186913-D9EEA6FD-A5AB-42BF-B143-D52FE2D4701BQ24187258-084603AA-A8D3-4B44-BE79-26B9A4B964E3Q24187460-259A9EFC-674D-460A-9447-D8D476B5F204Q24187543-78A74A3A-E652-4B97-9561-FBCD16993818Q24187751-E197F191-B9F1-4FCB-8C44-A82C9C6EDB0BQ24198288-8556B1EF-7B4E-46B6-96F1-CD2098E92B6BQ24198774-F8134DE2-9AFC-4944-8719-3104EF15CC02Q24198795-03F438D3-BFFF-4C79-A864-127A740B7777Q24198832-7023CFBD-99E4-4A5E-8B5B-00001B79DFD9Q26471928-F75AEC10-0C7E-46FB-9346-F92CB3FEB7E9Q27320898-447A2745-466D-4936-B25D-4DEC5C919F8BQ28249969-142D1995-E659-4F19-9A52-4D4F7B210206Q30248355-E9DB0543-1BE2-49B2-9256-CC6610678F1CQ33410860-31BD065B-773D-49E7-9646-C1268873853BQ33413225-1D873A11-8647-4135-8309-0234BB2847DDQ33415057-B3029F6C-B829-4CDB-ACC6-560C1B78E31DQ33421355-6CE4B22E-D53C-466B-B373-45F02DDF986CQ33430451-99F9E1B3-A4CE-43F6-9252-7646AE409D33Q39201474-E3AA71A1-189D-4CCC-9E0E-A7F5391D7A7AQ41480992-44E45A9E-1AF5-4B44-87A6-BB747646240CQ45785249-C214DD9A-84C5-457A-83C2-9137CC384FA0Q47293235-2F1A9139-8EB8-431F-9B93-E141BCFA5FE9Q48197715-F8B0EDCD-F09C-4360-AC16-8837854B9B8CQ49899043-E44EE243-7875-4024-A9B7-2713F3911668Q57689341-68F211C0-197E-4CC0-9A66-1D2502A6D07A
P2860
Platelet transfusions in haematology patients: are we using them appropriately?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Platelet transfusions in haematology patients: are we using them appropriately?
@en
Platelet transfusions in haematology patients: are we using them appropriately?
@nl
type
label
Platelet transfusions in haematology patients: are we using them appropriately?
@en
Platelet transfusions in haematology patients: are we using them appropriately?
@nl
prefLabel
Platelet transfusions in haematology patients: are we using them appropriately?
@en
Platelet transfusions in haematology patients: are we using them appropriately?
@nl
P2093
P2860
P1433
P1476
Platelet transfusions in haematology patients: are we using them appropriately?
@en
P2093
P2860
P304
P356
10.1111/J.1423-0410.2012.01627.X
P577
2012-07-09T00:00:00Z